Reply to "Does disease ontogeny matter more than JAK2 mutation status in acute myeloid leukemia?".

Albliwi M, Nurse DP, Zabor EC, Hanna J, El-Asmar J, Bawwab A, Abuamsha H, Abu-Farsakh Y, Batah H, Rauf A, Nakitandwe J, Bosler DS, Parthasarathy PB, Alban T, Jain AG, Molina JC, Balderman S, Singh A, Gerds AT, Mukherjee S, Advani AS, Carraway HE, Mustafa Ali MK

Open source

DOI
10.1002/cncr.70593
Published
2026 Sep 1
Container
Cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cncr.70593,
  title = {Reply to "Does disease ontogeny matter more than JAK2 mutation status in acute myeloid leukemia?".},
  author = {Albliwi M and Nurse DP and Zabor EC and Hanna J and El-Asmar J and Bawwab A and Abuamsha H and Abu-Farsakh Y and Batah H and Rauf A and Nakitandwe J and Bosler DS and Parthasarathy PB and Alban T and Jain AG and Molina JC and Balderman S and Singh A and Gerds AT and Mukherjee S and Advani AS and Carraway HE and Mustafa Ali MK},
  year = {2026},
  journal = {Cancer},
  doi = {10.1002/cncr.70593},
  url = {https://doi.org/10.1002/cncr.70593}
}

RIS

TY  - JOUR
TI  - Reply to "Does disease ontogeny matter more than JAK2 mutation status in acute myeloid leukemia?".
AU  - Albliwi M
AU  - Nurse DP
AU  - Zabor EC
AU  - Hanna J
AU  - El-Asmar J
AU  - Bawwab A
AU  - Abuamsha H
AU  - Abu-Farsakh Y
AU  - Batah H
AU  - Rauf A
AU  - Nakitandwe J
AU  - Bosler DS
AU  - Parthasarathy PB
AU  - Alban T
AU  - Jain AG
AU  - Molina JC
AU  - Balderman S
AU  - Singh A
AU  - Gerds AT
AU  - Mukherjee S
AU  - Advani AS
AU  - Carraway HE
AU  - Mustafa Ali MK
PY  - 2026
JO  - Cancer
DO  - 10.1002/cncr.70593
UR  - https://doi.org/10.1002/cncr.70593
ER  - 

APA

M, A., DP, N., EC, Z., J, H., J, E., A, B., H, A., Y, A., H, B., A, R., J, N., DS, B., PB, P., T, A., AG, J., JC, M., S, B., A, S., AT, G., S, M., AS, A., HE, C., & MK, M. A. (2026). Reply to "Does disease ontogeny matter more than JAK2 mutation status in acute myeloid leukemia?".. Cancer. https://doi.org/10.1002/cncr.70593

Source records